110 related articles for article (PubMed ID: 23299845)
21. Lymph node assessment in melanoma.
Easson AM; Rotstein LE; McCready DR
J Surg Oncol; 2009 Mar; 99(4):176-85. PubMed ID: 19065639
[TBL] [Abstract][Full Text] [Related]
22. Why perform sentinel-lymph-node biopsy in patients with melanoma?
Rosenberg SA
Nat Clin Pract Oncol; 2008 Jan; 5(1):1. PubMed ID: 18097452
[No Abstract] [Full Text] [Related]
23. Regional lymph node dissections in malignant melanoma.
Lawton GP; Ariyan S
Clin Plast Surg; 2000 Jul; 27(3):431-40, ix. PubMed ID: 10941563
[TBL] [Abstract][Full Text] [Related]
24. An aberrant lymph node containing metastatic melanoma detected by sentinel node biopsy.
Moloney DM; Overstall S; Allan R; Powell BW
Br J Plast Surg; 2001 Oct; 54(7):638-40. PubMed ID: 11583504
[TBL] [Abstract][Full Text] [Related]
25. Pelvic sentinel lymph node biopsy in melanoma patients: is it worthwhile?
Soteldo J; Ratto EL; Gandini S; Trifirò G; Mazzarol G; Tosti G; Rastrelli M; Verrecchia F; Baldini F; Testori A
Melanoma Res; 2010 Apr; 20(2):133-7. PubMed ID: 20087232
[TBL] [Abstract][Full Text] [Related]
26. Re: Selective lymphadenectomy in sentinel node-positive patients may increase the risk of local/in-transit recurrence in malignant melanoma, Thomas and Clark.
Pawlik TM; Ross MI; Shaw HM; Thompson JF; Gershenwald JE
Eur J Surg Oncol; 2005 Apr; 31(3):323-4. PubMed ID: 15780572
[No Abstract] [Full Text] [Related]
27. Update on the sentinel lymph node procedure in vulvar cancer.
Oonk MH; van de Nieuwenhof HP; van der Zee AG; de Hullu JA
Expert Rev Anticancer Ther; 2010 Jan; 10(1):61-9. PubMed ID: 20014886
[TBL] [Abstract][Full Text] [Related]
28. High positive sentinel node identification rate by EORTC melanoma group protocol. Prognostic indicators of metastatic patterns after sentinel node biopsy in melanoma.
van Akkooi AC; de Wilt JH; Verhoef C; Graveland WJ; van Geel AN; Kliffen M; Eggermont AM
Eur J Cancer; 2006 Feb; 42(3):372-80. PubMed ID: 16403622
[TBL] [Abstract][Full Text] [Related]
29. Predictive factors for false negative sentinel lymph node in melanoma patients.
Panasiti V; Devirgiliis V; Curzio M; Roberti V; Gobbi S; Rossi M; Bottoni U; Clerico R; Scuderi N; Calvieri S
Dermatol Surg; 2010 Oct; 36(10):1521-8. PubMed ID: 20698871
[TBL] [Abstract][Full Text] [Related]
30. Evolving treatment strategies in thin cutaneous head and neck melanoma: 1 institution's experience.
Jaber JJ; Clark JI; Muzaffar K; Ruggiero FP; Feustel PJ; Frett MJ; Zender CA
Head Neck; 2011 Jan; 33(1):7-12. PubMed ID: 20848424
[TBL] [Abstract][Full Text] [Related]
31. New TNM melanoma staging system: linking biology and natural history to clinical outcomes.
Balch CM; Buzaid AC; Soong SJ; Atkins MB; Cascinelli N; Coit DG; Fleming ID; Gershenwald JE; Houghton A; Kirkwood JM; McMasters KM; Mihm MF; Morton DL; Reintgen DS; Ross MI; Sober A; Thompson JA; Thompson JF
Semin Surg Oncol; 2003; 21(1):43-52. PubMed ID: 12923915
[TBL] [Abstract][Full Text] [Related]
32. Update on lymphatic mapping and sentinel node biopsy in the management of patients with melanocytic tumours.
Cochran AJ; Roberts A; Wen DR; Huang RR; Itakura E; Luo F; Binder SW
Pathology; 2004 Oct; 36(5):478-84. PubMed ID: 15370119
[TBL] [Abstract][Full Text] [Related]
33. Sentinel lymph node biopsy in cutaneous melanoma: a case-control study.
Koskivuo I; Talve L; Vihinen P; Mäki M; Vahlberg T; Suominen E
Ann Surg Oncol; 2007 Dec; 14(12):3566-74. PubMed ID: 17924169
[TBL] [Abstract][Full Text] [Related]
34. [Cutaneous melanoma and sentinel lymph node biopsy: where are we today?].
Girod A; Salmon R; Rodriguez J
Bull Cancer; 2007 Jul; 94(7):687-91. PubMed ID: 17723951
[TBL] [Abstract][Full Text] [Related]
35. Utility of computed tomography and magnetic resonance imaging staging before completion lymphadenectomy in sentinel lymph node-positive melanoma.
Miranda EP
J Clin Oncol; 2006 Nov; 24(32):5178; author reply 5178. PubMed ID: 17093288
[No Abstract] [Full Text] [Related]
36. Unnecessary axillary node dissections in the sentinel lymph node era.
Intra M; Rotmensz N; Mattar D; Gentilini OD; Vento A; Veronesi P; Colleoni M; De Cicco C; Cassano E; Luini A; Veronesi U
Eur J Cancer; 2007 Dec; 43(18):2664-8. PubMed ID: 17931853
[TBL] [Abstract][Full Text] [Related]
37. Completion axillary lymph node dissection not required for regional control in patients with breast cancer who have micrometastases in a sentinel node.
Yegiyants S; Romero LM; Haigh PI; DiFronzo LA
Arch Surg; 2010 Jun; 145(6):564-9. PubMed ID: 20566977
[TBL] [Abstract][Full Text] [Related]
38. Complete lymph node dissection for regional nodal metastasis.
Dzwierzynski WW
Clin Plast Surg; 2010 Jan; 37(1):113-25. PubMed ID: 19914463
[TBL] [Abstract][Full Text] [Related]
39. The chances of a patient with melanoma developing in transit disease are doubled by undergoing sentinel lymph node biopsy (SLNB).
Russell-Jones R; Powell AM; Acland K; Calonje E; O'Doherty M; Healy C
Eur J Surg Oncol; 2005 Mar; 31(2):210-1. PubMed ID: 15698741
[No Abstract] [Full Text] [Related]
40. [Study of variations between surgeons regarding inguinal lymph node clearance in melanoma].
Danino MA; Trost O; Malka G; Garrido I; Jebrane A; Dalac S
Ann Dermatol Venereol; 2008 Feb; 135(2):142-4. PubMed ID: 18342100
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
